Natera, Inc.

NTRA

Precision medicineHealthcare diagnosticsGenomic analysis

$327.94vs prev close▼-4.09(-1.23%)

$157.4352W Range$333.56

97% from low

+63.20 (+24.12%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

5 sells

Consecutive sells

1M net buy

-$15.0M

≈ -53K shares

Portfolio Weight

1.05%

1M -0.23%p

Holding ETFs

2 ETFs

ARKG · ARKK

Sell · Weight Down

ARK net-sold the stock and the price fell, decreasing its portfolio weight.

Shares -23.0% · Market value -25.5% · Weight -0.23%p

Trade Intensity

Concentrated sells

Basis: 5 sells · 0 buys in 1M · weight -0.23%p decrease

Trade Log5-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.08.17	SELL	ARKK	20,308	$314.18	$6.4M
26.08.04	SELL	ARKK	3,189	$275.19	$877.6K
26.08.03	SELL	ARKK	18,060	$270.36	$4.9M
26.07.29	SELL	ARKK	4,495	$253.82	$1.1M
26.07.28	SELL	ARKK	6,771	$252.22	$1.7M
26.07.20	SELL	ARKK	11,231	$262.63	$2.9M
26.07.16	SELL	ARKK	19,375	$269.83	$5.2M
26.07.09	SELL	ARKG · ARKK	26,429	$281.85	$7.4M
26.07.08	SELL	ARKG · ARKK	16,946	$274.39	$4.6M
26.07.07	SELL	ARKG · ARKK	20,992	$281.27	$5.9M
26.06.15	SELL	ARKK	6,319	$216.97	$1.4M
26.06.11	SELL	ARKK	25,674	$219.23	$5.6M
26.05.13	BUY	ARKG · ARKK	17,316	$195.32	$3.4M
26.05.12	BUY	ARKG · ARKK	4,310	$204.21	$880.1K
26.05.11	BUY	ARKG · ARKK	31,103	$199.14	$6.2M

08.17SELL

20,308

ARKKClose$314.18Est. total$6.4M

08.04SELL

3,189

ARKKClose$275.19Est. total$877.6K

08.03SELL

18,060

ARKKClose$270.36Est. total$4.9M

07.29SELL

4,495

ARKKClose$253.82Est. total$1.1M

07.28SELL

6,771

ARKKClose$252.22Est. total$1.7M

07.20SELL

11,231

ARKKClose$262.63Est. total$2.9M

07.16SELL

19,375

ARKKClose$269.83Est. total$5.2M

07.09SELL

26,429

ARKG · ARKKClose$281.85Est. total$7.4M

07.08SELL

16,946

ARKG · ARKKClose$274.39Est. total$4.6M

07.07SELL

20,992

ARKG · ARKKClose$281.27Est. total$5.9M

06.15SELL

6,319

ARKKClose$216.97Est. total$1.4M

06.11SELL

25,674

ARKKClose$219.23Est. total$5.6M

05.13BUY

17,316

ARKG · ARKKClose$195.32Est. total$3.4M

05.12BUY

4,310

ARKG · ARKKClose$204.21Est. total$880.1K

05.11BUY

31,103

ARKG · ARKKClose$199.14Est. total$6.2M

1 / 4

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

3 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

475,218

Portfolio Weight

1.05%

in ETF 3.97%

Est. Value

$131M

30D Net

-$35M

Philippe LaffontCoatue Management

Increased

208,418

Portfolio Weight

1.36%

Est. Value

$48M

vs Prev Quarter

+5304% (4K→208K)

Stanley DruckenmillerDuquesne Family Office

Increased

2,511,357

Portfolio Weight

13.66%

Est. Value

$575K

vs Prev Quarter

+2411% (100K→2.5M)

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Strong Buy

Buy

Hold

Analyst Targets

avg.

$336.74

vs Current ▲ +1.4% upside

Current$332.03

Low ~ High$280.00 ~ $375.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Citigroup

Buy

$365.00

+9.93%

—

Maintain

2026-08-13

Piper Sandler

Overweight

$363.50

+9.48%

—

Maintain

2026-08-12

Stephens & Co.

Overweight

$350.00

+5.41%

—

Maintain

2026-08-12

Guggenheim

Buy

$360.00

+8.42%

—

Maintain

2026-08-12

TD Cowen

Buy

$340.00

+2.40%

—

Maintain

2026-08-07

1 / 4

Avg Target

$336.74

vs Current ▲ +1.4% upside

Strong Buy

22 analysts

Strong Buy 5Buy 14Hold 3

Low $280.00

Current $332.03

High $375.00

Firm	Position	Target	Upside	Close	Action	Date
Citigroup	Buy	$365.00	+9.93%	—	Maintain	26.08.13
Piper Sandler	Overweight	$363.50	+9.48%	—	Maintain	26.08.12
Stephens & Co.	Overweight	$350.00	+5.41%	—	Maintain	26.08.12
Guggenheim	Buy	$360.00	+8.42%	—	Maintain	26.08.12
TD Cowen	Buy	$340.00	+2.40%	—	Maintain	26.08.07

1 / 4

Price Information

Previous Close$324.84

Open$321.61

Day Range$320.41 - $332.98

52-Week Range$157.43 - $333.56

1-Year Change104.36%

Trading Volume

Volume1,214,658

Avg Volume (3mo)1,448,196

Valuation

Market Cap47.9B

Book Value$12.43

Shares Outstanding144,144,170

Financials

Revenue (TTM)2.7B

Net Income-192,346,000

EPS$-1.36

EBITDA-224,420,992

Profitability

P/E Ratio-

P/B Ratio26.71

Return on Equity (ROE)-12.54%

Return on Assets (ROA)-8.08%

Profit Margin-7.11%

EV/EBITDA-209.46

Beta1.51

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)76.23

Company Overview

Natera, Inc. is a diagnostics company that provides molecular testing services globally. Their main products include genetic tests for prenatal screening (Panorama, Vistara), carrier screening (Horizon), cancer screening (Empower, Signatera), and transplant monitoring (Prospera). Natera serves various healthcare providers and research entities, positioning itself as a leader in advanced genetic diagnostics.

P/B

26.71

High valuation

ROE

-12.5%

Net loss

Beta

1.51

High volatility

RSI(14)

76.2

Overbought

AI-generated summary. Not investment advice.

Natera, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks